Eventide Asset Management - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 172 filers reported holding GW PHARMACEUTICALS PLC in Q2 2017. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.

Quarter-by-quarter ownership
Eventide Asset Management ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q4 2020$23,774,000
-44.0%
206,000
-52.8%
0.36%
-56.1%
Q3 2020$42,445,000
-20.7%
436,0000.0%0.83%
-28.5%
Q2 2020$53,506,000
+40.1%
436,0000.0%1.16%
-5.9%
Q1 2020$38,181,000
-16.2%
436,0000.0%1.24%
-3.8%
Q4 2019$45,588,000
+126.5%
436,000
+149.1%
1.28%
+93.2%
Q3 2019$20,130,000
-33.3%
175,0000.0%0.66%
-27.5%
Q2 2019$30,168,000
+92.4%
175,000
+88.2%
0.92%
+70.1%
Q1 2019$15,678,000
+153.5%
93,006
+46.5%
0.54%
+96.7%
Q4 2018$6,184,000
-43.6%
63,5000.0%0.27%
-32.0%
Q3 2018$10,969,000
+23.8%
63,5000.0%0.40%
+9.5%
Q2 2018$8,861,000
+23.8%
63,5000.0%0.37%
+9.9%
Q1 2018$7,155,000
-14.6%
63,5000.0%0.34%
-23.3%
Q4 2017$8,383,000
+30.1%
63,5000.0%0.44%
+19.7%
Q3 2017$6,445,000
+1.2%
63,5000.0%0.36%
-7.8%
Q2 2017$6,366,000
-17.1%
63,5000.0%0.40%
-22.0%
Q1 2017$7,680,000
+8.2%
63,5000.0%0.51%
+10.0%
Q4 2016$7,096,000
-15.8%
63,5000.0%0.46%
-10.3%
Q3 2016$8,428,000
+25.2%
63,500
-13.6%
0.52%
+25.0%
Q2 2016$6,730,000
+26.9%
73,5000.0%0.41%
+39.2%
Q1 2016$5,303,000
+3.9%
73,5000.0%0.30%
+16.1%
Q4 2015$5,104,000
-18.7%
73,500
+7.0%
0.26%
-30.1%
Q3 2015$6,277,000
+41.5%
68,700
+90.3%
0.36%
+52.1%
Q2 2015$4,435,000
+45.3%
36,100
+7.8%
0.24%
+4.3%
Q1 2015$3,053,000
+80.4%
33,500
+34.0%
0.23%
+24.3%
Q4 2014$1,692,000
-16.3%
25,0000.0%0.18%
-34.4%
Q3 2014$2,021,000
-24.6%
25,0000.0%0.28%
-22.7%
Q2 2014$2,682,00025,0000.36%
Other shareholders

There were no reported owners of GW PHARMACEUTICALS PLC in Q2 2017.

NameSharesValueWeighting ↓
View complete list of GW PHARMACEUTICALS PLC shareholders